RECOMMENDATIONS FOR CONGRESS
Sustain and – where possible – increase funding for global health research and product development. Policymakers must ensure future federal budgets prioritize a commitment to global health research and innovation, with robust funding across the U.S. government for R&D programs.
Where they have discretion, U.S. agencies and programs engaged in global health should set a percentage of disease- or health-related budgets to be directed to R&D. Agencies – including the Centers for Disease Control and Prevention (CDC), Department of Defense (DoD), Food & Drug Administration (FDA), National Institutes for Health (NIH), and the U.S. Agency for International Development (USAID) – must prioritize funding for developing global health technologies within existing programs and activities.
Establish a whole-of-government, coordinated global health R&D strategy. The U.S. government should create an overarching strategy to define how agencies work together, set government-wide priorities, leverage funding and expertise, fill gaps in the product development pipeline, and facilitate effective partnerships and transfers of research within government. It should also support a portfolio approach to investment in global health R&D to ensure data is guiding decision making and funds can be transferred as needed.
Support a portfolio of incentives and financing mechanisms to stimulate needed R&D at all stages of the product development process. Targeted and strategic incentive mechanisms, like prizes, advanced market commitments, and tax credits, could help incentivize greater private sector engagement in R&D for neglected diseases and conditions and bridge the divide between need and availability.
Support the capacity of local innovators to meet the health needs of their own countries through the development of high-value, affordable technologies. Through new partnerships, leveraged funding, and tailorable technical assistance, the U.S. can support local innovators to navigate R&D barriers and turn good ideas into lifesaving technologies. Local innovation is key to developing products that are affordable, accessible, and locally appropriate, and it also builds sustainable pathways to create jobs, economic stability, and health systems after countries graduate from traditional aid.